These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27918774)

  • 21. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis.
    Bissonnette R; Maari C; Provost N; Bolduc C; Nigen S; Rougier A; Seite S
    J Cosmet Dermatol; 2010 Mar; 9(1):16-21. PubMed ID: 20367668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence.
    Hebert AA; Rippke F; Weber TM; Nicol NH
    Am J Clin Dermatol; 2020 Oct; 21(5):641-655. PubMed ID: 32524381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines.
    Rozenbaum MH; Sanders EA; van Hoek AJ; Jansen AG; van der Ende A; van den Dobbelsteen G; Rodenburg GD; Hak E; Postma MJ
    BMJ; 2010 Jun; 340():c2509. PubMed ID: 20519267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory and severity evaluation of pediatric atopic dermatitis and moisturizer response in different phenotypes.
    Batmaz SB
    Allergol Immunopathol (Madr); 2018; 46(6):571-577. PubMed ID: 29980402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old.
    J Drugs Dermatol; 2019 Oct; 18(10):1020-1027. PubMed ID: 31584781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of partially-hydrolyzed formula for prevention of atopic dermatitis in Australia.
    Su J; Prescott S; Sinn J; Tang M; Smith P; Heine RG; Spieldenner J; Iskedjian M
    J Med Econ; 2012; 15(6):1064-77. PubMed ID: 22630113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. State medicaid coverage of over-the-counter moisturizers: A cost-effective management strategy for atopic dermatitis?
    Scollan ME; Garzon MC; Lauren CT
    Pediatr Dermatol; 2022 Sep; 39(5):838-845. PubMed ID: 35960142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moisturizer effect on irritant dermatitis: an overview.
    Yokota M; Maibach HI
    Contact Dermatitis; 2006 Aug; 55(2):65-72. PubMed ID: 16930228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost effectiveness of Elidel in the management of patients with atopic dermatitis in Canada.
    Coyle D; Barbeau M
    J Cutan Med Surg; 2004; 8(6):405-10. PubMed ID: 15988554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid-Free Over-the-Counter Eczema Skin Care Formulations Reduce Risk of Flare, Prolong Time to Flare, and Reduce Eczema Symptoms in Pediatric Subjects With Atopic Dermatitis.
    Weber TM; Samarin F; Babcock MJ; Filbry A; Rippke F
    J Drugs Dermatol; 2015 May; 14(5):478-85. PubMed ID: 25942666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme.
    Mason JM; Carr J; Buckley C; Hewitt S; Berry P; Taylor J; Cork MJ
    BMC Dermatol; 2013 May; 13():7. PubMed ID: 23679991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema.
    Pitt M; Garside R; Stein K
    Br J Dermatol; 2006 Jun; 154(6):1137-46. PubMed ID: 16704646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of Emollients in the Prevention of Relapse among French Patients with Atopic Dermatitis.
    Cabout E; Eymere S; Launois R; Séité S; Delvigne V; Taïeb C; Reguai Z
    Acta Derm Venereol; 2021 Jul; 101(7):adv00509. PubMed ID: 34230978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moisturizer therapy in prevention of atopic dermatitis and food allergy: To use or disuse?
    Katibi OS; Cork MJ; Flohr C; Danby SG
    Ann Allergy Asthma Immunol; 2022 May; 128(5):512-525. PubMed ID: 35235817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study.
    Udompataikul M; Srisatwaja W
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):660-5. PubMed ID: 20840345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review.
    Lindh JD; Bradley M
    Am J Clin Dermatol; 2015 Oct; 16(5):341-59. PubMed ID: 26267423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness and cost-effectiveness of the implantable miniature telescope.
    Brown GC; Brown MM; Lieske HB; Lieske PA; Brown KS; Lane SS
    Ophthalmology; 2011 Sep; 118(9):1834-43. PubMed ID: 21723614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new moisturizer containing physiologic lipid granules alleviates atopic dermatitis.
    Na JI; Hwang JS; Park HJ; Kim DH; Park WS; Youn SW; Huh CH; Park KC
    J Dermatolog Treat; 2010 Jan; 21(1):23-7. PubMed ID: 19626524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of partially hydrolyzed whey protein formula in the primary prevention of atopic dermatitis in high-risk urban infants in Southeast Asia.
    Botteman M; Detzel P
    Ann Nutr Metab; 2015; 66 Suppl 1():26-32. PubMed ID: 25925338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of Corticosteroid Nasal Spray vs Surgical Therapy in Patients With Severe to Extreme Anatomical Nasal Obstruction.
    Teti VP; Akdagli S; Most SP
    JAMA Facial Plast Surg; 2016 May; 18(3):165-70. PubMed ID: 26747790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.